HeartSciences Inc.

Nasdaq:HSCSNasdaq:HSCSW

Orthopedic, Prosthetic & Surgical Appliances & Supplies·SOUTHLAKE, TX

Summary Financials

Revenue

$18,600

+261.2% YoY

FY 2025

Adj. EBITDA

-$6.3M

-33752.0% margin

FY 2025

Net Income

-$6.6M

-35511.9% margin

FY 2025

EPS (Diluted)

-$18.74

FY 2025

Stock Price

$2.61

-1.7%

2026-03-10

52W Range

$2.01 – $6.47

P/E Ratio

-0.1x

Market Cap

$8.3M

Cash

$5.8M

FY 2025

Total Debt

$500,000

FY 2025

Net Cash

$5.3M

FY 2025

Enterprise Value

$3.0M

Debt / EBITDA

0.8x

FY 2025

EV / EBITDA

-0.5x

Employees

—

Revenue

$18,600

+261.2% YoY

FY 2025

Adj. EBITDA

-$6.3M

-33752.0% margin

FY 2025

Net Income

-$6.6M

-35511.9% margin

FY 2025

EPS (Diluted)

-$18.74

FY 2025

Stock Price

$2.61

-1.7%

2026-03-10

52W Range

$2.01 – $6.47

P/E Ratio

-0.1x

Market Cap

$8.3M

Cash

$5.8M

FY 2025

Total Debt

$500,000

FY 2025

Net Cash

$5.3M

FY 2025

Enterprise Value

$3.0M

Debt / EBITDA

0.8x

FY 2025

EV / EBITDA

-0.5x

Employees

—